Oruka Therapeutics, Inc. Payments of Stock Issuance Costs
Oruka Therapeutics, Inc. (ORKA) reported Payments of Stock Issuance Costs of $1.59 million for the 5-month period ending 2024-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-08-11
- Oruka Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Oruka Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Oruka Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2021-06-30 was $0.00.
- Oruka Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2021-03-31 was $977.00K.
- Oruka Therapeutics, Inc. payments of stock issuance costs for fiscal 2021 was $977.00K, a 51.97% decline from fiscal 2020.
- Oruka Therapeutics, Inc. payments of stock issuance costs for fiscal 2020 was $2.03M, a 446.77% increase from fiscal 2019.
- Oruka Therapeutics, Inc. payments of stock issuance costs for fiscal 2019 was $372.00K, a 217.95% increase from fiscal 2018.
- Oruka Therapeutics, Inc. payments of stock issuance costs for fiscal 2018 was $117.00K, a 73.88% decline from fiscal 2017.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 5 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 135 month |
|---|---|---|---|---|---|---|
| 2024-06-30 | $1.59M 10-Q · filed 2025-08-11 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-02-24 | $977.00K 10-K · filed 2023-02-24 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $0.00 derived: sum of 2 quarters · filed 2022-10-28 | $977.00K 10-Q · filed 2022-10-28 | $1.11M derived: sum of 4 quarters · filed 2022-10-28 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $977.00K 10-Q · filed 2022-08-02 | $1.11M derived: sum of 3 quarters · filed 2022-08-02 | $2.50M derived: sum of 4 quarters · filed 2022-08-02 | ||
| 2021-03-31 | $977.00K 10-Q · filed 2022-05-02 | $1.11M derived: sum of 2 quarters · filed 2022-05-02 | $2.50M derived: sum of 3 quarters · filed 2022-05-02 | |||
| 2020-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.52M derived: sum of 2 quarters · filed 2022-03-14 | $2.03M 10-K · filed 2022-03-14 | |||
| 2020-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.91M 10-Q · filed 2021-11-02 | ||||
| 2020-06-30 | $514.00K 10-Q · filed 2021-08-04 | |||||
| 2019-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $85.00K derived: sum of 2 quarters · filed 2021-03-18 | $255.00K derived: sum of 3 quarters · filed 2021-03-18 | $372.00K 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $251.00K derived: sum of 2 quarters · filed 2020-11-02 | $368.00K 10-Q · filed 2020-11-02 | $368.00K derived: sum of 4 quarters · filed 2020-11-02 | ||
| 2019-06-30 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $287.00K 10-Q · filed 2020-08-05 | $287.00K derived: sum of 3 quarters · filed 2020-08-05 | $287.00K derived: sum of 4 quarters · filed 2020-08-05 | ||
| 2019-03-31 | $117.00K 10-Q · filed 2020-05-06 | $117.00K derived: sum of 2 quarters · filed 2020-05-06 | $117.00K derived: sum of 3 quarters · filed 2020-05-06 | $118.00K derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $0.00 derived: sum of 2 quarters · filed 2020-02-18 | $1.00K derived: sum of 3 quarters · filed 2020-02-18 | $117.00K 10-K · filed 2020-02-18 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.00K derived: sum of 2 quarters · filed 2019-11-06 | $117.00K 10-Q · filed 2019-11-06 | $146.00K derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2018-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $117.00K 10-Q · filed 2019-08-01 | $146.00K derived: sum of 3 quarters · filed 2019-08-01 | $344.00K derived: sum of 4 quarters · filed 2019-08-01 | ||
| 2018-03-31 | $116.00K 10-Q · filed 2019-05-08 | $145.00K derived: sum of 2 quarters · filed 2019-05-08 | $343.00K derived: sum of 3 quarters · filed 2019-05-08 | $459.00K derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2017-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $227.00K derived: sum of 2 quarters · filed 2019-02-27 | $343.00K derived: sum of 3 quarters · filed 2019-02-27 | $448.00K 10-K · filed 2019-02-27 | ||
| 2017-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $314.00K derived: sum of 2 quarters · filed 2018-11-14 | $419.00K 10-Q · filed 2018-11-14 | |||
| 2017-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $221.00K 10-Q · filed 2018-08-09 | ||||
| 2017-03-31 | $105.00K 10-Q · filed 2018-05-08 | |||||
| 2015-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $203.00K derived: sum of 2 quarters · filed 2017-03-21 | $2.81M 10-K · filed 2017-03-21 | |||
| 2015-09-30 | $145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $2.76M 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | $2.61M 10-Q · filed 2016-08-09 | |||||
| 2014-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $2.00K derived: sum of 2 quarters · filed 2016-03-17 | $836.00K 10-K · filed 2016-03-17 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $834.00K 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | $834.00K 10-Q · filed 2015-08-11 | |||||
| 2013-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$20.00K 10-Q · filed 2013-11-13 | ||||
| 2013-06-30 | -$30.00K 10-Q · filed 2013-08-13 | |||||
| 2013-03-31 | $60.00K 10-Q · filed 2013-05-13 | |||||
| 2012-03-31 | $60.00K 10-Q · filed 2013-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |